AI News NQ Analysis

NEC Group's blood testing service 'FonesVisuas' adopted by Royal Healthcare, a medical institution for high-net-worth individuals in Singapore

NQ Score 50/100

AI Summary (NQ-processed)

NEC's blood testing service adopted in Singapore.

AI analysis data is not yet available.

Frequently Asked Questions

Q: Which medical institution in Singapore has adopted the FonesVisuas Test service?
A: Royal Healthcare, a medical institution based in Singapore and a subsidiary of Sojitz Corporation, has adopted the service.
Q: Where is Royal Healthcare located within Singapore?
A: Royal Healthcare is based in Novena, which is a medical hub located in Singapore.
Q: How does the FonesVisuas service analyze and visualize the state of the body?
A: The service analyzes proteins that change daily from a small amount of blood to visualize the body's current state.
Q: What specific diseases can the FonesVisuas service predict the risk of developing?
A: It predicts the risk of developing dementia, myocardial infarction, stroke, lung cancer, chronic kidney failure, and prostate cancer.
Q: What is NEC's future plan regarding the expansion of the FonesVisuas service?
A: NEC intends to expand the sales of FonesVisuas overseas, with a specific focus on the APAC region.